Edward R Lavallie Selected Research

Edward R Lavallie Research Topics

2	Inflammation (Inflammations) 05/2011 - 09/2010
2	Osteoarthritis 02/2010 - 01/2008
1	Edema (Dropsy) 05/2011
1	Fistula 05/2011
1	Cardiomegaly (Heart Hypertrophy) 05/2011
1	Heart Failure 05/2011
1	Infections 05/2011
1	Pneumococcal Pneumonia 05/2011
1	Sepsis (Septicemia) 05/2011
1	Fibrosis (Cirrhosis) 09/2010
1	Type 2 Diabetes Mellitus (MODY) 09/2010
1	Hypertrophy 09/2010
1	Autoimmune Diseases (Autoimmune Disease) 05/2010
1	Cytokine Release Syndrome 05/2010
1	Synovial Sarcoma (Synovioma) 02/2010
1	Pain (Aches) 02/2010
1	Arthralgia (Joint Pain) 02/2010
1	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 05/2008
1	Muscular Dystrophies (Muscular Dystrophy) 05/2008
1	Hypersensitivity (Allergy) 05/2008
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 05/2008

2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 05/2011 - 09/2010
2	Biomarkers (Surrogate Marker)IBA 05/2011 - 09/2010
1	2,4-thiazolidinedione (thiazolidinedione)IBA 05/2011
1	Receptor for Advanced Glycation End ProductsIBA 05/2011
1	Rosiglitazone (Avandia)FDA Link 05/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2011
1	Monoclonal AntibodiesIBA 05/2011
1	LigandsIBA 05/2011
1	SaltsIBA 05/2011
1	Hypoglycemic Agents (Hypoglycemics)IBA 09/2010
1	PPAR gammaIBA 09/2010
1	Ion Channels (Ion Channel)IBA 09/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2010
1	Interleukin-21 ReceptorsIBA 05/2010
1	interleukin-21 (interleukin 21)IBA 05/2010
1	ProstaglandinsIBA 02/2010
1	Prostaglandins EIBA 02/2010
1	Dinoprostone (PGE2)FDA Link 02/2010
1	GW 3965IBA 02/2010
1	CytokinesIBA 02/2010
1	Neutralizing AntibodiesIBA 05/2008
1	MyostatinIBA 05/2008
1	StamulumabIBA 05/2008
1	Aggrecans (Aggrecan)IBA 01/2008
1	Peptide Hydrolases (Proteases)FDA Link 01/2008

1	Oral Administration 02/2010